Alcon's AcrySof IQ PanOptix Receives the US FDA's Approval as the First Trifocal Lens for Patients Undergoing Cataract Surgery in the US
Shots:
- Alcon launches PanOptix Trifocal Intraocular Lens (IOL) to delivers a combination of near- intermediate and distance vision while reducing the need for glasses. Alcon plans to train US Ophthalmologist and to begin patient awareness program in H1’20
- The approval of PanOptix is based on a pivotal study conducted at 12 sites in the US- demonstrated high patient satisfaction with >99% patients saying they would choose the same lens again
- The AcrySof IQ PanOptix Trifocal IOL is a multifocal used to focus images clearly onto the retina to allow clear vision after the cataract removal- utilizes ENLIGHTEN optical technology to optimize intermediate vision without compromising near and distance vision and is available in spherical and toric designs
Click here to read full press release/ article | Ref: Alcon | Image: CODET Vision Institute
Tuba was Senior Editor at PharmaShots. She was curious, creative, and passionate about recent updates and innovations in the life sciences industry. She covered Biopharma, MedTech, and Digital health segments. Tuba also had an experience in digital and social media marketing and ran the campaigns independently. She can be contacted at [email protected]
